Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective

Brian Godman*, Eleonora Allocati, Evelien Moorkens

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Siu et al. c omprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications. The current situation in Canada is compared with similar initiatives across different countries to enhance savings from biosimilars to improve the affordability of biologicals.

Original languageEnglish
Pages (from-to)93-97
Number of pages5
JournalGaBI Journal
Volume8
Issue number3
DOIs
Publication statusPublished - 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective'. Together they form a unique fingerprint.

Cite this